Article 11(2) of Regulation (EU) 2021/2282 requires the health technology developer to proactively inform the Coordination Group where new clinical data becomes available during the joint clinical assessment process. In order to ensure, on the one hand, the smooth conduct of the joint clinical assessment and the compliance with the deadlines for the finalisation of the joint clinical assessment report and, on the other hand, legal certainty for the health technology developer, the deadline should be set at a date in which the JCA Subgroup is to ensure that the new clinical data received by that date are considered in the draft joint clinical assessment and summary reports.
Recital 24, Regulation (EU) 2025/2086
In forcesince 17 Oct 2025